1 ETF That’s Crushing Even Warren Buffett
Warren Buffett's Berkshire Hathaway has rarely been beaten by any fund for lengthy periods of time. But this ETF is doing it in spades. Here's how.
Celgene Delivers as Expected in Q2, but Raises New Questions
Celgene once again trounces Wall Street's expectations in the second quarter, but this earnings report also came with a few surprises.